(Q45928216)

17 December 2017

title

Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. (English)

1 reference

17 December 2017

0 references

1 reference

K Elisabet Ohlin

2

0 references

M. Angela Cenci Nilsson

series ordinal

3

object named as

M Angela Cenci

1 reference

17 December 2017

author name string

Hanna S Lindgren

series ordinal

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

15 July 2009

1 reference

17 December 2017

published in

Neuropsychopharmacology

1 reference

17 December 2017

volume

34

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

2477-2488

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/npp.2009.74

exact match

0 references

cites work

Hyperosmotic stimulus induces reversible angiogenesis within the hypothalamic magnocellular nuclei of the adult rat: a potential role for neuronal vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Dopaminergic Receptors Linked to Adenylate Cyclase in Human Cerebromicrovascular Endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Regional variation in brain capillary density and vascular response to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Advances in understanding L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Differential inhibition of neurogenesis and angiogenesis by corticosterone in rats stimulated with electroconvulsive seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Nitric oxide and the cerebral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Risperidone-induced tardive dystonia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Smoking and ischemic stroke: a role for nicotine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Exercise induces angiogenesis but does not alter movement representations within rat motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Global spatial sampling with isotropic virtual planes: estimators of length density and total length in thick, arbitrarily orientated sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Nicotine and Parkinson's disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Long-term treatment of Parkinson's disease with bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Effects of dopamine agonists and antagonists on locomotor activity in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Neurovascular signalling defects in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Levodopa therapy: consequences of the nonphysiologic replacement of dopamine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Proliferation and differentiation of rat neuroepithelial precursor cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

The efficiency of systematic sampling in stereology and its prediction.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Pertussis toxin induces angiogenesis in brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

alpha(2)-adrenergic receptor-mediated increase in NO production buffers renal medullary vasoconstriction

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.74

7 January 2021

Identifiers

DOI

10.1038/NPP.2009.74

1 reference

17 December 2017

Dimensions Publication ID

1048571955

0 references

1 reference

17 December 2017